Home

Jorey Chernett

CIK 2042077 · last filed 2026-08-17

Jorey Chernett is a corporate insider who has filed 36 SEC Form 4 insider transactions across 4 companies since 2026. The most recent filing, for TOI, was dated Aug 17, 2026. Across all open-market trades the lifetime net is +$9.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $49.2M across reported positions. 5 SEC filings were submitted jointly with NOVOGEN LTD.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$49.20M

Companies

4

Total Filings

36

Lifetime Open-Market Net

$9.48M

Filer Profile

Reported Address
6222 INDIANWOOD TR.
BLOOMFIELD HILLS, MI 48301
Related Filers
NOVOGEN LTD — 5 joint filings, latest 2026-08-19
Lineage Cell Therapeutics, Inc. — 1 joint filings, latest 2025-09-26
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Oncology Institute, Inc. (TOI) Delisted 10%+ Owner 10,660,858 $5.13 $54.69M $351.4K 4 2026-08-17
STIM 10%+ Owner 10,602,988 $3.03 $32.13M $4.81M 11 2026-08-17
Oncology Institute, Inc. (TOIIW) Delisted 10%+ Owner 10,579,858 $0.05 $518.4K $2.33M 9 2026-06-05
AIRS 10%+ Owner 7,053,761 $2.42 $17.07M $1.99M 12 2026-04-20

Recent Filings

36 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-17 Oncology Institute, Inc. (TOI) Delisted Mixed +12,000 $78.5K EDGAR
2026-08-17 STIM Mixed +14,000 $44.2K EDGAR
2026-07-22 Oncology Institute, Inc. (TOI) Delisted Buy (P) +18,000 $94.9K EDGAR
2026-07-15 STIM Buy (P) +35,000 $62.3K EDGAR
2026-07-13 Oncology Institute, Inc. (TOI) Delisted Buy (P) +15,000 $87.8K EDGAR
2026-06-24 Oncology Institute, Inc. (TOI) Delisted Buy (P) +18,000 $90.4K EDGAR
2026-06-05 Oncology Institute, Inc. (TOIIW) Delisted Buy (P) +12,000 $57.0K EDGAR
2026-05-21 Oncology Institute, Inc. (TOIIW) Delisted Buy (P) +38,500 $156.6K EDGAR
2026-05-20 STIM Buy (P) +100,000 $117.0K EDGAR
2026-05-20 Oncology Institute, Inc. (TOIIW) Delisted Buy (P) +30,000 $122.7K EDGAR
Showing 1–10 of 36
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.